Metabolism as a Target for Modulation in Autoimmune Diseases

Area of Science:

• Immunology
• Metabolic pathways
• Autoimmune diseases

Background:

• Metabolic pathways are crucial regulators of immune cell differentiation and activation.
• These pathways significantly influence the development of autoimmune diseases, including systemic lupus erythematosus (SLE).

Purpose of the Study:

• To review the pathways controlling reactive oxygen species (ROS) production and mechanistic target of rapamycin (mTOR) activation.
• To identify potential therapeutic targets for modulating the signaling network in autoimmune diseases, with a focus on SLE.

Main Methods:

• Literature review of metabolic pathways, ROS production, and mTOR signaling in the context of SLE.
• Analysis of the interplay between metabolic stress, ROS, and mTOR in immune cell function.

Main Results:

• mTOR acts as a key sensor of metabolic stress and mediator of pro-inflammatory responses.
• ROS production is controlled by metabolic pathways and promotes mTOR activation.
• ROS also modulates the antigenicity of cellular components, contributing to SLE pathogenesis.

Conclusions:

• The intricate relationship between metabolic pathways, ROS, and mTOR is central to SLE pathogenesis.
• Targeting these pathways offers potential for novel therapeutic strategies for SLE and other autoimmune conditions.